Breath Biopsies 2019: A Revolutionary Approach for Noninvasive Diagnosis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 22, 2019--
The “Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis” report has been added to ResearchAndMarkets.com’s offering.
In the future, a variety of conditions may be diagnosed with a simple breath test. Researchers are looking beyond blood tests and solid/liquid biopsies to find other sources of information to diagnose disease. Every time an individual breathes, thousands of volatile organic compounds (VOCs) and volatile fatty acids (VFAs), the breakdown products of lipids and proteins,1 are released into the breath. These novel biomarkers are by-products of metabolism, and can provide a snapshot of an individual’s health.
Key Topics Covered:
Chapter 1 Monitoring Volatile Organic Compounds
Chapter 2 Value Proposition of Breath Testing
Chapter 3 Applications in Diagnostics
Chapter 4 Companies and Technologies for Which to Watch Out
Chapter 5 References
For more information about this report visit https://www.researchandmarkets.com/r/vhlmxq
View source version on businesswire.com:https://www.businesswire.com/news/home/20191122005194/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 11/22/2019 06:09 AM/DISC: 11/22/2019 06:09 AM